Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 1
2014 1
2015 1
2016 3
2017 2
2018 2
2019 2
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
A kinase profile-adapted drug combination elicits synergistic cooperative effects on leukemic cells carrying BCR-ABL1T315I in Ph+ CML.
Gleixner KV, Sadovnik I, Schneeweiss M, Eisenwort G, Byrgazov K, Stefanzl G, Berger D, Herrmann H, Hadzijusufovic E, Lion T, Valent P. Gleixner KV, et al. Among authors: byrgazov k. Leuk Res. 2019 Mar;78:36-44. doi: 10.1016/j.leukres.2018.12.013. Epub 2018 Dec 28. Leuk Res. 2019. PMID: 30711891 Free PMC article.
CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML.
Schneeweiss-Gleixner M, Byrgazov K, Stefanzl G, Berger D, Eisenwort G, Lucini CB, Herndlhofer S, Preuner S, Obrova K, Pusic P, Witzeneder N, Greiner G, Hoermann G, Sperr WR, Lion T, Deininger M, Valent P, Gleixner KV. Schneeweiss-Gleixner M, et al. Among authors: byrgazov k. EBioMedicine. 2019 Dec;50:111-121. doi: 10.1016/j.ebiom.2019.11.004. Epub 2019 Nov 21. EBioMedicine. 2019. PMID: 31761618 Free PMC article.
Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia.
Gleixner KV, Schneeweiss M, Eisenwort G, Berger D, Herrmann H, Blatt K, Greiner G, Byrgazov K, Hoermann G, Konopleva M, Waliul I, Cumaraswamy AA, Gunning PT, Maeda H, Moriggl R, Deininger M, Lion T, Andreeff M, Valent P. Gleixner KV, et al. Among authors: byrgazov k. Haematologica. 2017 Sep;102(9):1519-1529. doi: 10.3324/haematol.2016.163436. Epub 2017 Jun 8. Haematologica. 2017. PMID: 28596283 Free PMC article.
BCR-ABL1 compound mutants display differential and dose-dependent responses to ponatinib.
Byrgazov K, Lucini CB, Valent P, Hantschel O, Lion T. Byrgazov K, et al. Haematologica. 2018 Jan;103(1):e10-e12. doi: 10.3324/haematol.2017.176347. Epub 2017 Oct 5. Haematologica. 2018. PMID: 28983061 Free PMC article. No abstract available.
The MazF-regulon: a toolbox for the post-transcriptional stress response in Escherichia coli.
Sauert M, Wolfinger MT, Vesper O, Müller C, Byrgazov K, Moll I. Sauert M, et al. Among authors: byrgazov k. Nucleic Acids Res. 2016 Aug 19;44(14):6660-75. doi: 10.1093/nar/gkw115. Epub 2016 Feb 22. Nucleic Acids Res. 2016. PMID: 26908653 Free PMC article.
Structural basis for the interaction of protein S1 with the Escherichia coli ribosome.
Byrgazov K, Grishkovskaya I, Arenz S, Coudevylle N, Temmel H, Wilson DN, Djinovic-Carugo K, Moll I. Byrgazov K, et al. Nucleic Acids Res. 2015 Jan;43(1):661-73. doi: 10.1093/nar/gku1314. Epub 2014 Dec 15. Nucleic Acids Res. 2015. PMID: 25510494 Free PMC article.
Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors.
Byrgazov K, Lucini CB, Berkowitsch B, Koenig M, Haas OA, Hoermann G, Valent P, Lion T. Byrgazov K, et al. Oncotarget. 2016 Nov 22;7(47):78083-78094. doi: 10.18632/oncotarget.12943. Oncotarget. 2016. PMID: 27801667 Free PMC article.
Ribosome heterogeneity: another level of complexity in bacterial translation regulation.
Byrgazov K, Vesper O, Moll I. Byrgazov K, et al. Curr Opin Microbiol. 2013 Apr;16(2):133-9. doi: 10.1016/j.mib.2013.01.009. Epub 2013 Feb 14. Curr Opin Microbiol. 2013. PMID: 23415603 Free PMC article. Review.
Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide.
Byrgazov K, Anderson C, Salzer B, Bozsaky E, Larsson R, Gullbo J, Lehner M, Lehmann F, Slipicevic A, Kager L, Fryknäs M, Taschner-Mandl S. Byrgazov K, et al. Ther Adv Med Oncol. 2020 Jul 29;12:1758835920937891. doi: 10.1177/1758835920937891. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32774473 Free PMC article.
Quantitative Analysis of Mutant Subclones in Chronic Myeloid Leukemia: Comparison of Different Methodological Approaches.
Preuner S, Barna A, Frommlet F, Czurda S, Konstantin B, Alikian M, Machova Polakova K, Sacha T, Richter J, Lion T, Gabriel C. Preuner S, et al. Among authors: konstantin b. Int J Mol Sci. 2016 Apr 29;17(5):642. doi: 10.3390/ijms17050642. Int J Mol Sci. 2016. PMID: 27136541 Free PMC article.
12 results
Jump to page
Feedback